Jennifer Petter is the founder and Chief Innovation Officer at Arrakis Therapeutics. Here she discusses the moments that led up to the founding of a successful biotech company built on a remarkable new approach in drug discovery: RNA-targeting small molecules. This back of the napkin conversation covers the standout moments in Jen’s career as well as some insightful perspectives into the future of drug discovery.

Arrakis Therapeutics Website: https://arrakistx.com/